Table of Contents
Table 5-33: Henry
Table 5-35: Huntington
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 179 | 447.4 | 1,041 | 530.0 | 104 | 269.3 | 508 | 270.2 |
| Esophagus | 6 | 17.4** | 27 | 13.9 | 5 | 13.4** | 26 | 13.4 |
| Stomach | * | # | 26 | 13.2 | * | # | 15 | 7.5** |
| Colon excluding Rectum | 11 | 29.6** | 85 | 44.8 | 10 | 24.6** | 49 | 25.6 |
| Rectum and Rectosigmoid Junction | 5 | 10.5** | 39 | 18.4 | * | # | 8 | 3.7** |
| Liver | * | # | 10 | 4.9** | * | # | 7 | 3.3** |
| Pancreas | 5 | 10.9** | 20 | 9.8 | 5 | 11.4** | 16 | 8.2** |
| Lung and Bronchus | 35 | 86.4 | 198 | 102.5 | 26 | 69.3 | 166 | 86.3 |
| Melanoma of the Skin | * | # | 31 | 15.4 | * | # | 6 | 3.0** |
| Prostate | 35 | 83.0 | 253 | 125.6 | 12 | 32.3** | 37 | 22.6 |
| Urinary Bladder | 13 | 32.3** | 74 | 39.4 | * | # | 17 | 10.1** |
| Kidney and Renal Pelvis | 7 | 19.1** | 32 | 16.5 | * | # | 16 | 8.6** |
| Brain and Other Nervous System | 6 | 16.1** | 25 | 12.2 | 6 | 14.3** | 17 | 8.5** |
| Non-Hodgkin Lymphoma | 7 | 18.6** | 40 | 20.4 | * | # | 21 | 11.0 |
| Myeloma | * | # | 6 | 3.4** | * | # | 10 | 5.6** |
| Leukemia | 6 | 14.7** | 29 | 15.0 | * | # | 19 | 10.3** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 213 | 409.0 | 1,073 | 419.4 | 87 | 162.0 | 475 | 177.7 |
| Colon excluding Rectum | 19 | 33.6** | 105 | 38.6 | 8 | 13.4** | 44 | 15.6 |
| Rectum and Rectosigmoid Junction | 5 | 9.6** | 36 | 13.6 | * | # | 7 | 2.7** |
| Liver | * | # | 8 | 3.0** | * | # | 8 | 3.1** |
| Pancreas | 10 | 18.3** | 27 | 10.0 | 9 | 16.2** | 24 | 8.8 |
| Lung and Bronchus | 25 | 47.8 | 160 | 61.0 | 22 | 41.7 | 134 | 50.8 |
| Melanoma of the Skin | * | # | 22 | 9.6 | * | # | 5 | 2.0** |
| Breast | 60 | 115.2 | 305 | 121.2 | 15 | 27.8** | 69 | 26.3 |
| Cervix Uteri | 8 | 17.6** | 24 | 11.0 | * | # | 9 | 3.8** |
| Corpus Uteri | 14 | 26.3** | 62 | 24.6 | * | # | 3 | # |
| Ovary | * | # | 36 | 14.4 | * | # | 24 | 9.1 |
| Urinary Bladder | * | # | 20 | 7.3 | * | # | 5 | 1.8** |
| Kidney and Renal Pelvis | 6 | 12.3** | 26 | 10.0 | * | # | 7 | 2.6** |
| Brain and Other Nervous System | * | # | 13 | 5.3** | * | # | 11 | 4.2** |
| Non-Hodgkin Lymphoma | 12 | 23.5** | 47 | 18.1 | * | # | 20 | 7.3 |
| Myeloma | * | # | 9 | 3.4** | * | # | 10 | 3.5** |
| Leukemia | 5 | 9.2** | 28 | 10.4 | * | # | 20 | 7.1 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-33: Henry
Table 5-35: Huntington
